Sonic Healthcare (OTCMKTS:SKHHY) Upgraded at The Goldman Sachs Group

Sonic Healthcare (OTCMKTS:SKHHY) was upgraded by equities research analysts at The Goldman Sachs Group to a “strong-buy” rating in a research report issued on Friday,Zacks.com reports.

Separately, Morgan Stanley set a $28.10 price target on Sonic Healthcare in a report on Wednesday, March 19th.

Sonic Healthcare Stock Performance

OTCMKTS:SKHHY opened at $15.62 on Friday. The firm’s 50-day moving average is $17.15 and its 200-day moving average is $17.58. Sonic Healthcare has a 52-week low of $15.24 and a 52-week high of $20.59.

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.